Grifols Files Routine 6-K Report
Ticker: GIKLY · Form: 6-K · Filed: Jul 19, 2024 · CIK: 1438569
| Field | Detail |
|---|---|
| Company | Grifols SA (GIKLY) |
| Form Type | 6-K |
| Filed Date | Jul 19, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, disclosure, foreign-private-issuer
TL;DR
Grifols filed a standard 6-K, no news here.
AI Summary
Grifols, S.A. filed a Form 6-K on July 19, 2024, to report other relevant information. The filing is a standard report for foreign private issuers and does not contain specific financial details or significant corporate actions beyond its routine nature.
Why It Matters
This filing is a routine disclosure for Grifols as a foreign private issuer, providing no new material information that would impact investors.
Risk Assessment
Risk Level: low — This is a routine filing with no new material information, thus posing a low risk.
Key Players & Entities
- Grifols, S.A. (company) — Registrant
- 001-35193 (company) — SEC File Number
- 241128608 (company) — Film Number
FAQ
What type of filing is this for Grifols, S.A.?
This is a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date for this report?
The filing date is July 19, 2024.
What is the principal executive office address of Grifols, S.A.?
The principal executive office is located at Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, 08174 Barcelona, Spain.
Does Grifols file under Form 20-F or Form 40-F?
Grifols, S.A. files annual reports under cover of Form 20-F.
What is the SIC code for Grifols, S.A.?
The Standard Industrial Classification (SIC) code for Grifols, S.A. is 2834, Pharmaceutical Preparations.
Filing Stats: 412 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-07-19 17:26:30
Filing Documents
- tm2419867d1_6k.htm (6-K) — 12KB
- tm2419867d1_6kimg001.jpg (GRAPHIC) — 136KB
- 0001104659-24-081204.txt ( ) — 200KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. Grifols, S.A. By: /s/ David I. Bell Name: David I. Bell Title: Authorized Signatory Date: July 19, 2024